FTC allows Amgen’s $27.8B purchase of Horizon to proceed

FTC allows Amgen’s $27.8B purchase of Horizon to proceed

Source: 
Medical Marketing and Media
snippet: 

The greenlight from the FTC marks a sudden turn in the Amgen-Horizon merger, one of the most pivotal business developments the industry had seen this year.